logo
Share SHARE
FONT-SIZE Plus   Neg

Insmed Names Will Lewis President, CEO, Effective Immediately - Quick Facts

Insmed Inc. (INSM) said it appointed Will Lewis as president and chief executive officer, or CEO, effective immediately. Lewis has also been appointed to the company's Board of Directors. Lewis succeeds Tim Whitten, who has resigned as president and CEO and as a member of Insmed's Board of Directors.

Lewis has above 20 years of executive experience and a track record of success in the pharmaceutical and finance industries both in the U.S. and internationally. He is the former co-founder, president and chief financial officer of Aegerion Pharmaceuticals, Inc. (AEGR). During his tenure at Aegerion, he played a pivotal role in re-orienting the company's strategy to focus on orphan disease indications enabling Aegerion to go public in one of the best performing IPOs of 2010. Before joining Aegerion, he spent more than 10 years working in the U.S. and Europe in investment banking for JP Morgan, Robertson Stephens and Wells Fargo.

In addition, Insmed noted that Donald Hayden, Jr., who was appointed as executive chairman in May 2012, will return to his role as chairman, effective immediately.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
International Consolidated Airlines Group S.A. Friday reported profit for the first quarter, compared to loss in the prior year, mainly reflecting higher passenger revenues and increased capacity. For fiscal 2016, IAG still expects to generate an absolute operating profit increase similar to 2015 as it expects to reduce underlying ex-fuel unit costs by around one percent. French drug maker Sanofi reported Friday a higher profit in its first quarter, while net sales were hurt mainly by weak results in Diabetes unit and Venezuela. Excluding Venezuela. Aggregate Group sales increased 3 percent at constant exchange rates. Looking ahead, the company continues to expect 2016 business earnings per share to be broadly stable at CER. LinkedIn Corp. (LNKD) on Thursday posted a loss for the first-quarter that widened from a year ago, hurt largely by higher operating costs. On an adjusted basis, earnings for the quarter improved and trumped Wall Street estimates, as revenues jumped 35 percent led by growth across all segments. Shares...
comments powered by Disqus
Follow RTT